Andrea Charles | 11/25/2013
In this exclusive interview Alain Pralong, VP New Product Introduction and Technical Life Cycle Management at GlaxoSmithKline Vaccines, speaks to Andrea Charles from Pharma IQ, about the challenges faced evaluating single-use systems for extractables and leachables and implementing single-use technology in biopharmaceutical manufacturing. Pralong also shares his opinion on the current regulatory landscape.
Have Your Say
Rate this feature...
To continue reading this story Click Here
RECOMMENDED
Digital Transformation in Pharma: Navigating CMO Partnerships and Supply Chain Resilience
2025-01-22
Sustainability and Inclusivity in Pharma Manufacturing: Insights from AstraZeneca’s People Hub
2024-12-11
Upcoming Events
Pharmaceutical Launch Excellence Summit
2 - 3 December, 2025
UK
Register Now |
View Agenda |
Learn More